|View printer-friendly version|
|December 29, 2000 3:34 p.m.|
|Israel Makov Appointed COO|
Jerusalem, December 29, 2000 - Jerusalem, Israel, December 29, 2000, Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) today announced the appointment of Israel Makov as Chief Operating Officer. Mr. Makov, who most recently served as Executive Vice President, was responsible for global business development and contributed to Teva's global growth through a strategy of mergers and acquisitions. During his tenure, Teva has developed a global organizational structure and has become the leading generic pharmaceutical company in the world.